Go to Top
X

Investors

  • Latest Investor News:
  • Aeon Global Health® Launches BDx Advantage™ - Extensive Blood Diagnostic Testing

    This new addition of blood testing offers clients a larger suite of services.

    GAINESVILLE, Ga., Feb. 23, 2017 /PRNewswire/ -- Authentidate Holding Corp. (OTC: ADAT), a provider of genetic hereditary cancer, molecular microbiology, pharmacogenomics, toxicology testing services, and secure, web-based software applications and telehealth products for healthcare organizations, today announced the addition of BDx Advantage™ Blood Diagnostic testing to their growing portfolio of
    Read More

Symbol Date Last Trade Trade Chg Open Volume
ADAT

5:00pm $2.15 +0.00(+0.00%) 2.15 9000


1d   5d   3m   6m   1y   2y   5y   msx